Study Shows PNA-PCR Superior to Sequencing for KRAS Mutation Detection | GenomeWeb

NEW YORK (GenomeWeb) – New research from an international team has concluded that a PCR-based technique called peptide-nucleic-acid-mediated PCR, or PNA-PCR, is significantly more sensitive than Sanger sequencing in detecting KRAS mutations in tumor tissue and plasma samples.  

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.